Revisiones_bibliográficas TyO

lunes, 21 de agosto de 2017

Los resultados y los factores que afectan después de la reparación artroscópica del tendón subescapular aislado.

http://www.mihombroycodo.com.mx/academia/los-resultados-y-los-factores-que-afectan-despues-de-la-reparacion-artroscopica-del-tendon-subescapular-aislado/

The outcomes and affecting factors after arthroscopic isolated subscapularis tendon repair.

Fuente

Este artículo es publicado originalmente en:

https://www.ncbi.nlm.nih.gov/pubmed/28735848

http://www.jshoulderelbow.org/article/S1058-2746(17)30288-4/fulltext

De:

Rhee YG1,Lee YS2,Park YB3,Kim JY4,Han KJ2,Yoo JC5.

J Shoulder Elbow Surg.

2017 Jul 20. pii: S1058-2746(17)30288-4. doi: 10.1016/j.jse.2017.05.017. [Epub ahead of print]

This study evaluated clinical outcomes for isolated subscapularis tendon tears treated by arthroscopic repair, the factors affecting clinical outcomes, and changes in tendon structural integrity using magnetic resonance imaging.

CONCLUSION:

Arthroscopic repair of isolated subscapularis tear provided significant functional improvements with a low rerupture rate. Age was significantly associated with clinical results.

KEYWORDS:

Arthroscopic repair; clinical outcomes; factors; isolated subscapularis tendon tear; structural integrity; subscapularis tear classification

Resumen

ANTECEDENTES:

En este estudio se evaluaron los resultados clínicos de los desgarres de tendón subscapular aislados tratados con reparación artroscópica, los factores que afectaron los resultados clínicos y los cambios en la integridad estructural de los tendones mediante resonancia magnética.

CONCLUSIÓN:
La reparación artroscópica de la rotura del subescapular aislada proporcionó mejoras funcionales significativas con una baja tasa de reruptura. La edad se asoció significativamente con los resultados clínicos.

PALABRAS CLAVE:

Reparación artroscópica; resultados clínicos; Factores; Ruptura del tendón subscapular aislada; integridad estructural; Clasificación de desgarro subescapularPMID: 28735848 DOI:

10.1016/j.jse.2017.05.017

#Reparación artroscópica #artroscopia #tendón subescapular #desgarre

jueves, 17 de agosto de 2017

Vasopresina / Vasopressin

Agosto 15, 2017. No. 2781

Papel de la vasopresina en la práctica anestésica actual

Role of vasopressin in current anesthetic practice.

Park KS, Yoo KY.

Korean J Anesthesiol. 2017 Jun;70(3):245-257. doi: 10.4097/kjae.2017.70.3.245. Epub 2017 May 26.

Abstract

Arginine vasopressin (AVP), also known as antidiuretic hormone, is a peptide endogenously secreted by the posterior pituitary in response to hyperosmolar plasma or systemic hypoperfusion states. When administered intravenously, it causes an intense peripheral vasoconstriction through stimulation of V1 receptors on the vascular smooth muscle. Patients in refractory shock associated with severe sepsis, cardiogenic or vasodilatory shock, or cardiopulmonary bypass have inappropriately low plasma levels of AVP ('relative vasopressin deficiency') and supersensitivity to exogenously-administered AVP. Low doses of AVP and its synthetic analog terlipressin can restore vasomotor tone in conditions that are resistant to catecholamines, with preservation of renal blood flow and urine output. They are also useful in the treatment of refractory arterial hypotension in patients chronically treated with renin-angiotensin system inhibitors, cardiac arrest, or bleeding esophageal varices. In the perioperative setting, they represent attractive adjunct vasopressors in advanced shock states that are unresponsive to conventional therapeutic strategies.

KEYWORDS: Arginine vasopressin; Hemorrhagic shock; Refractory hypotension; Septic shock; Terlipressin; Vasodilatory shock

PDF

XIV Congreso Virtual Mexicano de Anestesiología 2017

Octubre 1-Diciembre 31, 2017

Información / Information

California Society of Anesthesiologists

Reuniones / Events

Informacion / Information

Anestesiología y Medicina del Dolor

52 664 6848905

vwhizar@anestesia-dolor.org

anestesia-dolor.org

Vasopresores en shock hemorrágico / Vasopressors in hemorrhagic shock

Agosto 16, 2017. No. 2782

Vasopresores. ¿Tienen algún uso en shock hemorrágico?

Vasopressors: Do they have any role in hemorrhagic shock?

Gupta B1, Garg N2, Ramachandran R2.

J Anaesthesiol Clin Pharmacol. 2017 Jan-Mar;33(1):3-8. doi: 10.4103/0970-9185.202185.

Abstract

The priority in the management of patients with traumatic hemorrhagic shock is to control the bleeding with simultaneous volume resuscitation to maintain adequate tissue perfusion. Fluid replacement remains the mainstay of initial resuscitation in hemorrhagic shock. Traditionally, vasopressors are contraindicated in the early management of hemorrhagic shock due to their deleterious consequences, although vasopressors may have a role in resuscitation when vasoplegic shock ensues and blood pressure cannot be maintained by fluids alone. Use of vasopressors is not recommended according to the Advanced Trauma Life SupportR management principles. The role of vasopressors remains controversial with no clear guidelines on the timing, type, and dose of these drugs in hemorrhagic shock. Among vasopressors, norepinephrine and vasopressin have been used in the majority of the trials, although not many studies compare the effect of these two on long-term survival in trauma patients. This article reviews the pathophysiology of hemorrhagic shock, adverse effects of fluid resuscitation, and the various experimental and clinical studies on the use of vasopressors in the early phase of resuscitation in hemorrhagic shock.

KEYWORDS: Hemorrhagic; norepinephrine; shock; vasopressin; vasopressor agents

PDF

XIV Congreso Virtual Mexicano de Anestesiología 2017

Octubre 1-Diciembre 31, 2017

Información / Information

California Society of Anesthesiologists

Reuniones / Events

Informacion / Information